检索历史清除

首页> Multiple sclerosis: clinical and laboratory research> Randomised Placebo-controlled Phase 3 Study of Delayed-release Dimethyl Fumarate in Patients with Relapsing Multiple Sclerosis from Asia-Pacific and Other Countries

Randomised Placebo-controlled Phase 3 Study of Delayed-release Dimethyl Fumarate in Patients with Relapsing Multiple Sclerosis from Asia-Pacific and Other Countries

导出原文传递

翻译打印收藏纠错

作者： Saida, T. ^[1] ; Yamamura, T. ^[2] ; Kondo, T. ^[3] ; Yun, J. ^[4] ; Yang, M. ; Li, J. ; Mahadavan, L. ; Zhu, B. ; Sheikh, S. I.

作者单位： Biogen, Cambridge, MA USA ^[1] NCNP, Natl Ctr Hosp, Tokyo, Japan ^[2] Kyoto Univ, Grad Sch Med, Kyoto, Japan ^[3] Kyoto Min Iren Cent Hosp, Kansai Multiple Sclerosis Ctr, Kyoto, Japan ^[4]

发布时间 2018-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交